van Kan, HJ, Groeneveld, GJ, Kalmijn, S, Spieksma, M, van den Berg, LH, Guchelaar, HJ. Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis. „Br J Clin Pharmacol”. 59, s. 310-313, 2005. PMID: 15752377.
Miller, RG, Mitchell, JD, Lyon, M, Moore, DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). „Cochrane Database Syst Rev”. 2, s. CD001447, 2002. PMID: 17253460.
